The University of Chicago Header Logo

Connection

Thomas Mayer to Compassionate Use Trials

Back to Details
This is a "connection" page, showing publications Thomas Mayer has written about Compassionate Use Trials.
Thomas Mayer
Connection Strength
0.205
Compassionate Use Trials
  1. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany. Epilepsia. 2021 10; 62(10):2518-2527.
    View in: PubMed
    Score: 0.205
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.